About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024 07-11-2024 at 4:05 PM EDT Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress 05-31-2024 at 7:30 AM EDT Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference 05-29-2024 at 4:05 PM EDT VIEW ALL NEWS Upcoming Events & Presentations Adaptive Biotechnologies Second Quarter Financial Results Aug 1, 2024 at 4:30 PM EDT Add to Outlook Add to Google Calendar Listen to webcast Past Events & Presentations Goldman Sachs 45th Annual Global Healthcare Conference Jun 11, 2024 at 1:20 PM EDT Listen to webcast Adaptive Biotechnologies First Quarter Financial Results May 7, 2024 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q1 2024 Earnings Presentation 768 KB Adaptive Biotechnologies Business Update Apr 2, 2024 at 4:30 PM EDT Listen to webcast VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Jul 26, 2024 7:57 PM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.